Balanced news tone
News Sentiment
CDLX sentiment intelligence
Cardlytics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
47
Balanced news tone
57 relevant articles
News tone and price action are not far from neutral.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-3.9% over one week, -24.9% over four weeks, trend inactive, and below fair value.
CDLX News | CARDLYTICS INC (NASDAQ:CDLX)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
74/100 classification
One-week reaction
-3.9%
Price reacting lower
Trend fit
Trend inactive
-24.9% over four weeks
Fair value
-89.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
40
Negative
12
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
ChartMill
Direct company coverage
CDLX News | CARDLYTICS INC (NASDAQ:CDLX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 00:00
- Source
- ChartMill
TradingKey
Direct company coverage
Cardlytics Inc (CDLX) Institutional Confidence
Cardlytics Inc (CDLX) has an institutional shareholding score of 3.00, placing it 284th in the Software & IT Services industry, with a current institutional shareholding proportion of 36.29%. This represents a 39.44% decrease quarter-over-quarter. James Simons is the largest inst
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 17:09
- Source
- TradingKey
TradingKey
Direct company coverage
Cardlytics Inc (CDLX) Earnings Forecast: Future EPS & Revenue Growth Estimates
Cardlytics Inc (CDLX) has an earnings forecast score of 5.60, ranking 403 out of 489 in the Software & IT Services industry, with an average price target of $1.50 according to 5 analysts. The company's expected revenue for the next quarter is $36.89M, and EPS is forecasted at -$1
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 14:44
- Source
- TradingKey
TradingKey
Direct company coverage
Cardlytics Inc (CDLX) Dividends & Stock Splits: Historical Payouts and Event Timeline
Cardlytics Inc (CDLX) has not distributed any dividends over the past five years. However, the article notes a 10-for-1 merger type stock split that occurred on May 20, 2026. This page provides an overview of the company's dividend history and stock split events.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jun 2026 21:09
- Source
- TradingKey
TradingKey
Direct company coverage
Cardlytics Inc (CDLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Cardlytics Inc (CDLX), highlighting its regional revenue contributions. As of the latest data, the United States accounts for 87.01% of its revenue, totaling $202.97 million, while the United Kingdom contributes 12.99% with $30.30 mil
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 20:09
- Source
- TradingKey
TradingKey
Direct company coverage
Cardlytics Inc (CDLX) Financial Health: Profitability & Balance Sheet Analysis
This article provides a financial health analysis of Cardlytics Inc (CDLX), highlighting its current financial score of 6.00, which ranks 421 out of 489 in the Software & IT Services industry. The company's financial status is described as weak with average operating efficiency.
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 17 Jun 2026 16:40
- Source
- TradingKey
GuruFocus
Direct company coverage
Cardlytics Inc (FRA:CYX0) Stock Price & 30 Year Financial Data
This article provides 30-year financial data for Cardlytics Inc (FRA:CYX0), including its stock price, market capitalization, enterprise value, and various growth rates. It details historical revenue, EPS, EBIT, EBITDA, and Free Cash Flow growth over 10, 5, and 1-year periods, al
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 12 Jun 2026 09:09
- Source
- GuruFocus
TradingView
Direct company coverage
Return on equity % of Cardlytics, Inc. – MUN:CYX0
This article provides access to the "Return on equity %" financial data for Cardlytics, Inc. (CYX0) on the Munich Stock Exchange, available through TradingView. It indicates that the market is closed, and the data is sourced from ICE Data Services and FactSet Research Systems Inc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:38
- Source
- TradingView
GuruFocus
Direct company coverage
Q1 2025 Cardlytics Inc Earnings Call Transcript
This article provides the edited transcript of Cardlytics Inc.'s Q1 2025 earnings call. The company announced positive developments such as strong consumer spending data, the launch with a new large financial institution partner, and an expanded network beyond FIs. Despite these
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jun 2026 09:09
- Source
- GuruFocus
GuruFocus
Direct company coverage
Q3 2025 Cardlytics Inc Earnings Call Transcript
Cardlytics Inc (CDLX) reported a significant 20.3% decrease in Q3 total billings and a 22.4% revenue reduction due to content restrictions from its largest FY partner. Despite these challenges, the company successfully mitigated some billing drop by shifting volume to other partn
- Tone
- Negative 35/100
- Event
- Earnings
- Published
- 10 Jun 2026 09:09
- Source
- GuruFocus
TradingView
Direct company coverage
Long term debt to total assets ratio of Cardlytics, Inc. – GETTEX:CYX0
This article displays the long-term debt to total assets ratio for Cardlytics, Inc. (GETTEX:CYX0). It presents a data table showing the period, value, change, and change percentage for this financial metric, although the table itself is empty in the provided content. The surround
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 10 Jun 2026 06:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Cash Flow – GETTEX:CYX0
Cardlytics, Inc. (GETTEX:CYX0) reported a free cash flow of -4.91 million EUR for Q1 2026. For the full year 2025, the company had a free cash flow of 7.50 million EUR and an operating cash flow of 7.91 million EUR. The article provides historical cash flow data from 2015 to 2025
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 10 Jun 2026 05:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Balance Sheet – MUN:CYX0
Cardlytics, Inc. (MUN:CYX0) reported its Q1 2026 financial position, with total assets at 228.42 M EUR, a decrease of 6.08% from Q4 2025. Total liabilities also decreased by 6.78% to 231.88 M EUR in Q1 2026. The data reflects the company's current financial health.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 03:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Earnings and Revenue – TRADEGATE:CYX0
Cardlytics, Inc. (CYX0) reported earnings per share of -0.69 EUR, significantly beating the -3.20 EUR estimate by 78.38%. Revenue for the last quarter was 29.70M EUR, falling short of the 32.20M EUR estimate. Analysts project -1.99 EUR in earnings per share and 31.87M EUR in reve
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 10 Jun 2026 02:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Balance Sheet – TRADEGATE:CYX0
This article provides a brief overview of Cardlytics, Inc.'s balance sheet data as of Q1 2026, traded under TRADEGATE:CYX0. It states that total assets for Q1 2026 were 228.42 million EUR, a decrease from Q4 2025, and total liabilities also decreased to 231.88 million EUR in Q1 2
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 01:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Earnings and Revenue – MUN:CYX0
Cardlytics, Inc. (MUN:CYX0) reported Q1 earnings per share of -0.69 EUR, significantly beating the estimated -3.20 EUR. Despite beating EPS estimates, the company's revenue of 29.70M EUR fell short of the 32.20M EUR estimate. Analysts anticipate -1.99 EUR EPS and 31.99M EUR in re
- Tone
- Positive 72/100
- Event
- Earnings
- Published
- 09 Jun 2026 23:09
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Financial Statements – MUN:CYX0
This article provides financial information for Cardlytics, Inc. (MUN:CYX0) on the Munich Stock Exchange, covering key facts, company description, and financial metrics. It notes that there is currently no market capitalization, revenue, or net income data available and that the
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jun 2026 23:09
- Source
- TradingView
TradingView
Direct company coverage
Price to earnings ratio of Cardlytics, Inc. – TRADEGATE:CYX0
This page from TradingView provides financial information for Cardlytics, Inc. (TRADEGATE:CYX0), specifically focusing on its price-to-earnings ratio. The content lists various financial data points and includes links to community, forecasts, bonds, ETFs, and other market data. I
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jun 2026 22:40
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Revenue Breakdown – TRADEGATE:CYX0
Cardlytics, Inc. (CYX0) reported total revenue of 198.61 M EUR last year. The Cardlytics Platform segment was the primary revenue driver, generating 180.78 M EUR, a decrease from 246.92 M EUR in the previous year. The United States contributed the most geographically, accou
- Tone
- Negative 39/100
- Event
- Earnings
- Published
- 09 Jun 2026 22:40
- Source
- TradingView
TradingView
Direct company coverage
Cardlytics, Inc. Income Statement – TRADEGATE:CYX0
This article presents the income statement for Cardlytics, Inc. (CYX0) on the Tradegate Exchange. It highlights the company's financial performance, noting a total revenue of 29.70M EUR for the last quarter, which is a significant decrease from the previous quarter, and a net inc
- Tone
- Negative 29/100
- Event
- Earnings
- Published
- 09 Jun 2026 22:40
- Source
- TradingView
The Globe and Mail
Direct company coverage
Cardlytics Announces Reverse Stock Split Amid Nasdaq Deficiency
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- The Globe and Mail
Stock Titan
Direct company coverage
Cardlytics (NASDAQ: CDLX) enacts 1-for-10 reverse split after Nasdaq bid-price notice
Cardlytics (NASDAQ: CDLX) has received a notice from Nasdaq due to its common stock trading below $1.00 for 30 consecutive business days, risking delisting. To address this deficiency and modify its capital structure, the company has enacted a 1-for-10 reverse stock split and red
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 03 Jun 2026 20:11
- Source
- Stock Titan
TradingView
Direct company coverage
Cardlytics Disclosed Failure to Satisfy a Continued Listing Rule or Standard
Cardlytics, Inc. (CDLX) received a notice from Nasdaq on June 3, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days, thus breaching Listing Rule 5550(a)(2). The company has until November 30, 2026, to regain compliance and may consider a r
- Tone
- Negative 19/100
- Event
- Market update
- Published
- 03 Jun 2026 20:11
- Source
- TradingView
Stock Titan
Direct company coverage
Cardlytics (NASDAQ: CDLX) director converts 11K RSUs and receives 11K new units
Cardlytics (NASDAQ: CDLX) director Srishti A. Gupta reported routine equity compensation activity, exercising 11,000 restricted stock units (RSUs) to acquire 11,000 common shares and subsequently receiving a new grant of 11,000 RSUs. Following these transactions on May 20, 2026,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 05:40
- Source
- Stock Titan
Stock Titan
Direct company coverage
Andre J. Fernandez boosts Cardlytics (CDLX) equity via RSU exercise and new grant
Andre J. Fernandez, a director at Cardlytics, Inc. (CDLX), increased his equity-based holdings through a routine compensation activity. He exercised 11,000 restricted stock units (RSUs) which vested after one year and received a new grant of 11,000 RSUs, contingent on his continu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 05:08
- Source
- Stock Titan
Stock Titan
Direct company coverage
Scott A. Hill boosts Cardlytics (CDLX) equity via RSU exercise and new grant
Cardlytics director Scott A. Hill has increased his equity in the company through compensation-related transactions. He exercised 11,000 restricted stock units (RSUs) into common stock and received a new grant of 11,000 RSUs, which will vest after one year of board service. Follo
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 20:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
Director Liane Hornsey at Cardlytics (CDLX) logs 11,000-share RSU vest and new 11,000 RSU grant
Cardlytics director Liane Hornsey reported an 11,000-share RSU vest, converting them into common stock, and received a new grant of 11,000 Restricted Stock Units (RSUs). Following these transactions, she directly holds 33,326 common shares and has the new 11,000 RSUs which will v
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 20:39
- Source
- Stock Titan
The Globe and Mail
Direct company coverage
Analysts Are Neutral on Top Communication Services Stocks: Perion Network (PERI), Cardlytics (CDLX)
Analysts have issued neutral ratings for communication services stocks Perion Network (PERI) and Cardlytics (CDLX), indicating neither a bullish nor bearish outlook. Laura Martin from Needham maintained a Hold rating for Perion Network, while Jason Kreyer from Craig-Hallum also m
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 21 May 2026 16:39
- Source
- The Globe and Mail
AD HOC NEWS
Direct company coverage
Cardlytics Inc stock (US14161W1053): shareholders clear path for reverse split as volatility stays h
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- AD HOC NEWS
TipRanks
Direct company coverage
Cardlytics Shareholders Approve Reverse Split and Board Slate
Cardlytics (CDLX) shareholders recently approved a reverse stock split authorization, elected three Class II directors, and ratified Deloitte & Touche as the independent auditor. Despite advisory approval for executive pay, the company faces financial challenges highlighted by it
- Tone
- Negative 38/100
- Event
- Regulatory and legal
- Published
- 21 May 2026 04:09
- Source
- TipRanks